CASP1 and melanoma: The results showed a significant increase in activated caspase 1 for direct NTP treatment of both A375 (1.3 ± 0.2-fold change, p = 0.0139) and SK-MEL-28 (1.5 ± 0.2-fold change, p = 0.0018) melanoma cells (Fig. 4a).